Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome women notice changes to their menstrual cycle after starting semaglutide. The medicine itself is not known to directly disrupt periods, but the weight loss it supports can shift hormone levels enough to alter cycle length, flow, or regularity — and that distinction matters when you're trying to work out what's going on. These are prescription-only medicines; a clinician assesses your full picture before treatment begins and remains your point of contact if anything changes.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The core question many women bring to this topic is whether Wegovy itself is the culprit, or whether something else is happening. The honest answer is: probably both, and they're connected.
Adipose tissue (body fat) is metabolically active. It produces and stores oestrogen. When fat stores reduce, even by a modest amount, circulating oestrogen levels can shift. For some women that means lighter or less frequent periods; for others, particularly those who previously had irregular cycles linked to excess weight, periods can actually become more regular as treatment progresses.
Rapid weight loss of any kind (from surgery, illness, or medication) is a recognised trigger for temporary cycle disruption. Semaglutide's licensed information does not list menstrual changes as a direct side effect, but the NHS semaglutide medicines page and the broader clinical literature both acknowledge that hormonal changes associated with weight reduction can affect reproductive hormones. The SURMOUNT and STEP trial programmes were not designed to track menstrual endpoints, so formal data in this area remain limited.
The practical upshot: if your cycle changes noticeably in the first weeks of treatment, weight-related hormonal adjustment is the most likely explanation. That doesn't mean you should ignore it, it means you have a plausible reason to watch and report.
Wegovy side effects worth knowing about in this context are mainly gastrointestinal, nausea, vomiting, loose stools, and fatigue. These tend to be most noticeable after the first injection or after a dose increase, and they generally settle within a few days to two weeks as the body adjusts.
None of these directly cause menstrual pain, but they can amplify it. If you're already managing cramps and you add nausea and fatigue on top, the combined effect feels harder than either would alone. Some women find that keeping semaglutide in the fridge door and injecting on the same evening each week (alongside a small snack if needed) builds a routine that makes side effects more predictable and manageable.
For a fuller picture of what the gastrointestinal side effects look like over time, the full semaglutide side effects guide covers the trajectory in more detail. There's also a specific page on diarrhoea on Wegovy if that's the symptom giving you most trouble.
One practical note on contraception: the pill's absorption can be reduced during a bout of vomiting or prolonged diarrhoea, regardless of which medicine caused it. If you're relying on oral contraception and you experience significant GI symptoms early in treatment, speak to your prescriber about back-up contraception during that window. NHS England's guidance on weight-management injections covers this alongside other practical considerations for women on these medicines.
Cycle changes that settle after the first month or two are generally in line with what's expected during significant weight loss. The following warrant medical attention sooner rather than later.
Seek help promptly if: your periods stop entirely for three months or more (amenorrhoea); bleeding becomes unexpectedly heavy or prolonged; you experience severe pelvic pain; you think you might be pregnant (semaglutide is not recommended during pregnancy or while trying to conceive, stop the medicine and contact your GP or prescriber straight away); or you notice mood changes, persistent low mood, or thoughts of self-harm, which should always be taken seriously.
For symptoms not on that list but still worrying you (unusual spotting, very short cycles, anything that feels out of character for you) your prescriber is the right first call, not a wait-and-see approach. You can also report any suspected side effect through the MHRA's Yellow Card scheme, which helps regulators build a clearer picture of how these medicines behave in real-world use. That matters especially for an area like menstrual health, where trial data are sparse.
If you're still weighing up Wegovy against other options, the Wegovy overview page covers the full licensed indication, eligibility criteria, and what the clinical evidence shows on weight outcomes.
Yes, and the consultation is the right moment for it. If you have a history of irregular periods, endometriosis, PCOS, or are using hormonal contraception, those are all relevant clinical details that a prescriber needs to know before recommending treatment.
At nume, a GPhC-registered prescriber reads your consultation personally and considers your full medical picture, not a standard algorithm, not a checkbox form that skips the nuance. If menstrual health is a concern, raise it in your answers; it directly informs the clinical assessment.
Decisions about starting Wegovy are not just about eligibility criteria, they're about whether the medicine is right for you specifically. Our prescribers go through suitability and likely side effects as part of that conversation, and our guide to the side effects of semaglutide is a useful read before you begin. Aftercare support is available seven days a week if questions come up once treatment has started, and you can always reach us via the contact page.
For a broader look at the side-effect profile, this guide to semaglutide side effects covers the full range and how they're managed. If you're ready to talk through your options, check your eligibility with our clinical team.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.